BIOPHARMA HOLDING ApS: Financial statements 2021
CVR: 35206086
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 704,103 and a net result of DKK 12,015,703 compared with DKK 1,495,216 the year before. That is an increase of 19.2% compared with the year before. Equity in the 2021 report amounted to DKK 158,277,892. The solvency ratio was 94.6%.
- Gross Profit
- DKK 704,103
- Profit/Loss
- DKK 12,015,703
- Equity
- DKK 158,277,892
- Total Assets
- DKK 167,313,309
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 704K | 12M | 158.3M | - |
| 2020 | - | 591K | 1.5M | 146.3M | 1 |
| 2019 | - | 385K | 24.4M | 144.8M | 0 |
| 2018 | - | 405K | 1.4M | 120.4M | 0 |
| 2017 | - | 298K | -8.2M | 119M | 1 |
Official annual report
Find more companies like BIOPHARMA HOLDING ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
BIOPHARMA HOLDING ApS has published its annual report for 2020. Gross profit came to DKK 590,892, and the net result was DKK 1,495,216.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.